AMGN
33
3
D
48
3
DGX
46
3
FLS
55
3
AIV
51
3
HST
52
-2
NAVI
49
2
TRIP
66
3
PG
37
2
SHW
58
2
CPB
30
3
PNC
59
2
MS
59
-2
FTI
61
-5
NI
58
2
HPE
63
2
WEC
53
5
UNM
53
4
MMC
50
2
DE
56
3
AMGN
33
3
D
48
3
DGX
46
3
FLS
55
3
AIV
51
3
HST
52
-2
NAVI
49
2
TRIP
66
3
PG
37
2
SHW
58
2
CPB
30
3
PNC
59
2
MS
59
-2
FTI
61
-5
NI
58
2
HPE
63
2
WEC
53
5
UNM
53
4
MMC
50
2
DE
56
3
Financhill
Back

Protagenic Therapeutics 10K Form

Sell
9

PTIX
Protagenic Therapeutics

Last Price:
$3.53
Seasonality Move:
1.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PTIX News And Ratings

See the #1 stock for the next 7 days that we like better than PTIX

PTIX Financial Statistics

Sales & Book Value

Annual Sales: $85K
Cash Flow: $-1.1M
Price / Cash Flow: 0
Annual Sales: $-0.16
Price / Book: 1.61

Profitability

EPS (TTM): -13.10890
Net Income (TTM): $-5.2M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Protagenic Therapeutics Earnings Forecast

Key Protagenic Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for PTIX have been equal to 891.76% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 12 years.

Protagenic Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PTIX
Website: protagenic.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTIX Technical Analysis vs Fundamental Analysis

Sell
9
Protagenic Therapeutics (PTIX) is a Sell

Is Protagenic Therapeutics a Buy or a Sell?